China Pharma Holdings, Inc. (CPHI) Reports Q2 Loss of $0.05 on Revenues of $2.92M

China Pharma Holdings, Inc. (NYSE: CPHI) reported Q2 EPS of ($0.05). Revenue for the quarter came in at $2.92 million, versus $0 reported last year.

Second Quarter Highlights

• Revenue decreased 17.7% to $2.9 million in second quarter 2017 from $3.5 million in the same period of 2016;
• Gross profit margin was 22.2% in second quarter 2017, compared to 13.6% in the same period of 2016.
• Loss from operations was $2.1 million in second quarter 2017 compared to $2.2 million in the same period of 2016, a decrease of $0.1 million in loss;
• Net loss was $2.3 million in second quarter 2017 compared to $2.5 million in the same period of 2016. Loss per common share was $(0.05) per basic and diluted share in second quarter 2017 compared with $(0.06) per basic and diluted share in the same period of 2016.

For earnings history and earnings-related data on China Pharma Holdings, Inc. (CPHI) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
• Pan American Silver (PAAS) Misses Q2 EPS by 19c